Skip to content

MeiraGTx Holdings plc MGTX Change in receivables

Change in receivables at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$6.89M-427%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherReceivables.

The official record: MeiraGTx Holdings plc’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's change in receivables?
MeiraGTx Holdings plc (MGTX) reported change in receivables of $6.08M in Q4 2025.
How has MeiraGTx Holdings plc's change in receivables changed year-over-year?
MeiraGTx Holdings plc's change in receivables increased by 699.7% year-over-year, from -$1.01M to $6.08M.
What does change in receivables mean?
Change in total receivables including trade and non-trade receivables.